Company news

Share this article:
Pharmaceutical and healthcare research and advisory firm Decision Resources announced that it plans to acquire Wood Mackenzie's Life Sciences business. Financial terms of the deal were not disclosed. Wood MacKenzie's Life Sciences business comprises of market research, data and analysis on the commercial landscape of the biopharmaceutical industry and the animal health industry.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Panel votes against painkiller

Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."

Amgen sales rose by 5% in Q1

But demand for Enbrel and Aranesp slipped.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.